The company is developing bone re-growth stimulation technologies and has an adaptive stem cell line called Marrow Isolated Adult Multi-Lineage Inducible cells. Vivex aims to introduce its stem cell and implant technologies to the market by early 2014.
More Articles on Devices:
Alphatec Holdings to Reduce Workforce, Operating Expenses for French Affiliate
Trinity Orthopedics Acquires Expanding Concepts’ Patent Portfolio
8 Key Notes on Spine & Orthopedic Medical Device Companies
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
